HALP score as an independent prognostic biomarker for recurrence and progression in non–muscle-invasive bladder cancer: A retrospective cohort study

Key Points

• HALP score serves as an independent prognostic biomarker for disease recurrence and progression.
• In a cohort study involving non-muscle-invasive bladder cancer patients, HALP scores significantly correlated with adverse outcomes.
• This retrospective cohort study analyzed clinical data over several years, establishing the importance of HALP score assessments.
• The findings suggest implementing the HALP score may improve patient monitoring and outcomes in bladder cancer management.